Literature DB >> 29695401

Cytogenetics of Spindle Cell/Pleomorphic Lipomas: Karyotyping and FISH Analysis of 31 Tumors.

Ioannis Panagopoulos1, Ludmila Gorunova2, Marius Lund-Iversen3, Kristin Andersen2, Hege Kilen Andersen2, Ingvild Lobmaier3, Bodil Bjerkehagen3, Sverre Heim2,4.   

Abstract

BACKGROUND: Spindle cell/pleomorphic lipomas are benign tumors. Here, we present our cytogenetic data on 31 such tumors.
MATERIALS AND METHODS: G-banding chromosome analysis and (in selected cases) fluorescence in situ hybridization (FISH) using probes for FOXO1, RB1, and HMGA2 were performed.
RESULTS: Rearrangements of chromosome 13 were found in 58% of tumors. Chromosomes 6, 1, 12, and 11 were also involved in 42%, 26%, 26%, and 23% of tumors, respectively. FISH analysis showed heterozygous deletion of RB1 in seven samples with chromosome 13 aberrations. In four of them, FOXO1 was also deleted. In two tumors with 12q15 rearrangements, FISH confirmed that HMGA2 was targeted.
CONCLUSION: Structural rearrangements of 13q or losses of an entire chromosome 13 are the most common cytogenetic aberrations in spindle cell/pleomorphic lipomas. However, cytogenetic variation exists similarly to what is found in other lipomas, suggesting that various pathways may be responsible for tumorigenesis. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  FOXO1 gene; HMGA2 gene; RB1 gene; Spindle cell lipomas; chromosome 12; chromosome 13; cytogenetics; pleomorphic lipomas

Mesh:

Substances:

Year:  2018        PMID: 29695401      PMCID: PMC5971011          DOI: 10.21873/cgp.20077

Source DB:  PubMed          Journal:  Cancer Genomics Proteomics        ISSN: 1109-6535            Impact factor:   4.069


  32 in total

1.  Spindle cell lipoma.

Authors:  F M Enzinger; D A Harvey
Journal:  Cancer       Date:  1975-11       Impact factor: 6.860

2.  Consistent Involvement of Chromosome 13 in Angiolipoma.

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Kristin Andersen; Ingvild Lobmaier; Bodil Bjerkehagen; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2018 Jan-Feb       Impact factor: 4.069

3.  Distinct cytologic features of spindle cell lipoma. A cytologic-histologic study with clinical, radiologic, electron microscopic, and cytogenetic correlations.

Authors:  H A Domanski; B Carlén; K Jonsson; F Mertens; M Akerman
Journal:  Cancer       Date:  2001-12-25       Impact factor: 6.860

4.  Lesions of 13q may occur independently of deletion of 16q in spindle cell/pleomorphic lipomas.

Authors:  P Dal Cin; R Sciot; P Polito; M Stas; I de Wever; A Cornelis; H Van den Berghe
Journal:  Histopathology       Date:  1997-09       Impact factor: 5.087

5.  Spindle cell and pleomorphic lipoma: an immunohistochemical study and histogenetic analysis.

Authors:  A Beham; C Schmid; S Hödl; C D Fletcher
Journal:  J Pathol       Date:  1989-07       Impact factor: 7.996

6.  Spindle cell lipoma.

Authors:  Nil Comunoglu; Cem Comunoglu; A Işin Dogan Ekici; Ferda Ozkan; Sergülen Dervişoglu
Journal:  Pol J Pathol       Date:  2007       Impact factor: 1.072

7.  A new cytogenetic subgroup in lipomas: loss of chromosome 16 material in spindle cell and pleomorphic lipomas.

Authors:  N Mandahl; F Mertens; H Willén; A Rydholm; O Brosjö; F Mitelman
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

8.  Vulvovaginal angiomyofibroblastomas: morphologic, immunohistochemical, and fluorescence in situ hybridization analysis for deletion of 13q14 region.

Authors:  Gaetano Magro; Alberto Righi; Rosario Caltabiano; Laura Casorzo; Michal Michal
Journal:  Hum Pathol       Date:  2014-04-18       Impact factor: 3.466

9.  Rearrangement of chromosome bands 12q14~15 causing HMGA2-SOX5 gene fusion and HMGA2 expression in extraskeletal osteochondroma.

Authors:  Ioannis Panagopoulos; Bodil Bjerkehagen; Ludmila Gorunova; Ingeborg Taksdal; Sverre Heim
Journal:  Oncol Rep       Date:  2015-06-05       Impact factor: 3.906

10.  Spindle Cell Lipoma of the Neck: Review of the Literature and Case Report.

Authors:  Jacques A Machol; Jenna G Cusic; Elizabeth A O'Connor; James R Sanger; Hani S Matloub
Journal:  Plast Reconstr Surg Glob Open       Date:  2015-12-09
View more
  5 in total

1.  Fusion of the Genes PHF1 and TFE3 in Malignant Chondroid Syringoma.

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Marius Lund-Iversen; Assia Bassarova; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2019 Sep-Oct       Impact factor: 4.069

2.  NDRG1-PLAG1 and TRPS1-PLAG1 Fusion Genes in Chondroid Syringoma.

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Kristin Andersen; Marius Lund-Iversen; Ingvild Lobmaier; Francesca Micci; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2020 May-Jun       Impact factor: 4.069

3.  Recurrent Fusion of the Genes for High-mobility Group AT-hook 2 (HMGA2) and Nuclear Receptor Co-repressor 2 (NCOR2) in Osteoclastic Giant Cell-rich Tumors of Bone.

Authors:  Ioannis Panagopoulos; Kristin Andersen; Ludmila Gorunova; Marius Lund-Iversen; Ingvild Lobmaier; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2022 Mar-Apr       Impact factor: 4.069

Review 4.  Recurrent Fusion of the GRB2 Associated Binding Protein 1 (GAB1) Gene With ABL Proto-oncogene 1 (ABL1) in Benign Pediatric Soft Tissue Tumors.

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Kristin Andersen; Svetlana Tafjord; Marius Lund-Iversen; Ingvild Lobmaier; Francesca Micci; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2020 Sep-Oct       Impact factor: 4.069

5.  Fusion of the Paired Box 3 (PAX3) and Myocardin (MYOCD) Genes in Pediatric Rhabdomyosarcoma.

Authors:  Ioannis Panagopoulos; Ludmila Gorunova; Kristin Andersen; Marius Lund-Iversen; Svetlana Tafjord; Francesca Micci; Sverre Heim
Journal:  Cancer Genomics Proteomics       Date:  2021 Nov-Dec       Impact factor: 4.069

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.